Bristol Monopril market share tops 20% at Omnicare-affiliated nursing homes.
Executive Summary
BRISTOL MONOPRIL MARKET SHARE IS OVER 20% AT OMNICARE-AFFILIATED nursing homes within one year of being named a preferred ACE inhibitor on Omnicare's "Geriatric Pharmaceutical Care Guidelines," Omnicare said. Monopril's market share climbed from 2% in December 1994 to 20% at the end of 1995 and has gone even higher in early 1996, Omnicare said. Bristol-Myers Squibb highlights Monopril's performance in the Omnicare system in its recently released annual report.